Pacific Edge Cxbladder Monitor

Pacific Edge has launched the Cxbladder Monitor, a urine-based gene expression test for investigation of bladder cancer in patients being monitored for recurrent disease. The test analyzes urine samples for expression genes, clinical, and patient variable factors that create unique molecular signatures for urothelial carcinoma. It is designed to be used on patients undergoing bladder cancer surveillance to determine if they have a low probability of having recurrence.